U.S. markets close in 4 hours 23 minutes

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.06000.0000 (0.00%)
As of 11:32AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/12/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 352.21%
S&P500 52-Week Change 342.44%
52 Week High 34.0000
52 Week Low 31.1400
50-Day Moving Average 32.2423
200-Day Moving Average 32.1827

Share Statistics

Avg Vol (3 month) 3401.29k
Avg Vol (10 day) 3141.03k
Shares Outstanding 517.5M
Implied Shares Outstanding 6N/A
Float 14.73M
% Held by Insiders 115.94%
% Held by Institutions 18.76%
Shares Short (Apr 29, 2021) 4661.05k
Short Ratio (Apr 29, 2021) 44.18
Short % of Float (Apr 29, 2021) 45.67%
Short % of Shares Outstanding (Apr 29, 2021) 43.78%
Shares Short (prior month Mar 30, 2021) 4627.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-103.71%
Return on Equity (ttm)-195.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.93M
Net Income Avi to Common (ttm)-10.89M
Diluted EPS (ttm)-0.8740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.4M
Total Cash Per Share (mrq)0.25
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.41
Book Value Per Share (mrq)0.28

Cash Flow Statement

Operating Cash Flow (ttm)-7.63M
Levered Free Cash Flow (ttm)-3.57M